Bone-marrow transplantation and toxoplasmic retinochoroiditis

Graefes Arch Clin Exp Ophthalmol. 1987;225(3):239-43. doi: 10.1007/BF02175456.


A 33-year-old woman underwent bone-marrow transplantation following radiation and chemotherapy for chronic myelocytic leukemia (CML); immunosuppressive therapy was continued for graft-versus-host disease. Five months after successful transplantation, she developed necrotizing retinitis in both eyes with rapid progression over the following weeks. Due to her immunosuppressed state the patient developed pneumonia and died. Postmortem evaluation of the retinal lesions in both eyes disclosed infection by Toxoplasma gondii, which was also found in the brain and myocardium. Multiple viable toxoplasmic cysts were observed at the transition zone from a necrotic to a normal retina. Additionally, cysts of Toxoplasma gondii a normal retina. Additionally, cysts of Toxoplasma gondii were seen in the adjacent intact retina and in areas of necrosis with almost complete absence of retinal or choroidal inflammation. Toxoplasmosis should therefore be considered along with fungi and viruses in the differential diagnosis of necrotizing retinochoroiditis in immunocompromised patients.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Bone Marrow Transplantation*
  • Chorioretinitis / etiology*
  • Chorioretinitis / pathology
  • Female
  • Graft vs Host Disease / drug therapy
  • Humans
  • Leukemia, Myeloid / therapy
  • Toxoplasmosis, Ocular* / diagnosis


  • Adrenal Cortex Hormones